<DOC>
	<DOCNO>NCT01694836</DOCNO>
	<brief_summary>Specific immunotherapy IgE mediate sensitization birch pollen . Long-term study ass safety efficacy Depigoid ( R ) Birch 5000 - modify pollen extract Betula alba ( Birch ) - versus placebo .</brief_summary>
	<brief_title>Depigoid Birch 5000 Longterm Study Adults Adolescents</brief_title>
	<detailed_description>Investigation long-term efficacy safety Depigoid Birch 5000 accord perennial treatment regimen comparison placebo adult adolescent patient birch pollen-induced allergic rhinitis and/or rhinoconjunctivitis show superiority vs. placebo . As study include adolescent patient run approve PIP . Total study duration per patient 5 year : 3 year perennial treatment ( application study medication interval 4-6 week ) follow treatment-free observational phase 2 year ( season ) .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>Availability appropriately sign date informed consent study specific examination , Clinical history least 2 year seasonal allergic rhinitis and/or rhinoconjunctivitis without intermittent asthma due birch pollen allergy require repeat use symptomatic treatment , Patients must minimum level perception symptom previous season define least moderate symptom level ( i.e . score 2 4pointLikert scale ) least 2 symptom category prior randomization , Lung function ≥ 80 % predict normal value , IgEmediated sensitization verify : suggestive medical history , specific IgE reactivity birch pollen ( CAPRAST ≥ 2 ) , positive SPT birch pollen screen within 1 month prior screen visit . An SPT consider positive result wheal diameter least 3.0 mm Internet access patient complete eDiary daily via internet 5 pollen season cover study protocol . History significant clinical manifestation allergy result sensitization coallergies , particularly—but limit to—grass weed pollen perennial allergen ( e.g . house dust mite , cat dog ) . History anaphylactic reaction . Moderate severe persistent asthma ( GINA 3 4 ) . Mild persistent asthma ( GINA 2 ) , accord Global Initiative Asthma Guidelines , necessitate treatment inhaled glucocorticoid daily dose level &gt; 400 µg budesonide dose equivalent . Lung function &lt; 80 % predict normal value ( PEF : high result 3 measurement ) . Acute chronic inflammatory infectious airway disease include recurrent acute chronic sinusitis . Chronic structural disease affect organ ( e.g . eye , nose , lung ) . History presence confirm potential disease immune system include autoimmune disease immune deficiency actual clinical relevance . Any disease prohibits use adrenaline ( e.g . hyperthyroidism ) . Atopic dermatitis SCORAD &gt; 30 past screening . Ongoing past full course SIT birch pollen within last 5 year . Topical systemic treatment βblockers . Concomitant treatment substance interfere immune system begin 1 week prior start treatment . Use systemic corticosteroid within 3 month prior Visit 11 . Immunization vaccine within 7 day prior Visit 11 . Treatment antihistamines reason allergic symptom due birch pollen allergy . Changed residence geographical region since last birch pollen season stay geographical region predetermine birch pollen season . Nursing ( lactate ) woman woman positive pregnancy test screen visit . Women childbearing potential must use highly effective contraception participation clinical study . A highly effective method birth control define one result low failure rate ( i.e . le 1 % per year ) use consistently correctly , implant , injectables , combine oral contraceptive , IUDs , sexual abstinence , vasectomise partner .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Allergic rhinitis</keyword>
	<keyword>Allergic rhinoconjunctivitis</keyword>
	<keyword>Allergy induce asthma</keyword>
	<keyword>Birch ( Betula alba )</keyword>
	<keyword>Hayfever</keyword>
	<keyword>Immunotherapy</keyword>
</DOC>